Giardiasis Clinical Presentation
- Author: Sandeep Mukherjee, MB, BCh, MPH, FRCPC; Chief Editor: Julian Katz, MD more...
History
Clinical signs and symptoms if giardiasis include the following[5, 6, 15] :
- Diarrhea
- Malaise, weakness
- Abdominal distention
- Flatulence
- Abdominal cramps
- Nausea
- Malodorous, greasy stools
- Anorexia
- Weight loss
- Vomiting
- Low-grade fever (infrequent)
- Various neurologic symptoms (eg, irritability, sleep disorder, mental depression, neuroasthenia)
- Urticaria
Diarrhea is the most common symptom of acute Giardia infection, occurring in 90% of symptomatic subjects. Abdominal cramping, bloating, and flatulence occur in 70-75% of symptomatic patients.
Symptoms of chronic infection include chronic diarrhea, malaise, nausea, and anorexia. Weight loss, as extensive as 10-15 pounds in an adult, occurs in approximately 66% of symptomatic patients. Chronic sporadic diarrhea may continue for months. Postinfection lactose deficiency also is a common finding, occurring in 2-40% of cases.
Extraintestinal manifestations are rare and include allergic manifestations such as urticaria, erythema multiforme, bronchospasm, reactive arthritis, and biliary tract disease. The etiology of such extraintestinal symptoms is likely a result of host immune system activation and cross-reactivity/molecular mimicry.
Gastrointestinal manifestations
A small number of persons develop abrupt onset of explosive, watery diarrhea, abdominal cramps, foul flatus, vomiting, fever, and malaise; these symptoms last 3-4 days before transition into the more common subacute syndrome. Most patients experience a more insidious onset of symptoms, which are recurrent or resistant.
Stools become malodorous, mushy, and greasy. Watery diarrhea may alternate with soft stools or even constipation. Stools do not contain blood or pus.
Upper GI symptoms, often exacerbated by eating, accompany stool changes or may be present in the absence of soft stools. These include upper and midabdominal cramping, nausea, early satiety, bloating, sulfurous belching, substernal burning, and acid indigestion.
Constitutional symptoms
Anorexia, fatigue, malaise, and weight loss are common. Weight loss occurs in more than 50% of patients and averages 10 pounds.
Chronic illness may occur. Adults may present with long-standing malabsorption syndrome and children, with failure to thrive.
Physical Examination
Physical examination does not contribute to the diagnosis of giardiasis. Weight loss may be evident, but no known unique physical findings are attributable to giardiasis.
On abdominal examination, patients may have nonspecific tenderness without evidence of peritoneal irritation. Rectal examination should reveal heme-negative stools. In severe cases, evidence of dehydration or wasting may be present.
Complications
Complications of giardiasis may include the following:
Daly ER, Roy SJ, Blaney DD, Manning JS, Hill VR, Xiao L, et al. Outbreak of giardiasis associated with a community drinking-water source. Epidemiol Infect. Sep 15 2009;1-10. [Medline].
Robertson L, Gjerde B, Hansen EF, Stachurska-Hagen T. A water contamination incident in Oslo, Norway during October 2007; a basis for discussion of boil-water notices and the potential for post-treatment contamination of drinking water supplies. J Water Health. Mar 2009;7(1):55-66. [Medline].
Eisenstein L, Bodager D, Ginzl D. Outbreak of giardiasis and cryptosporidiosis associated with a neighborhood interactive water fountain--Florida, 2006. J Environ Health. Oct 2008;71(3):18-22; quiz 49-50. [Medline].
Nishi L, Baesso ML, Santana RG, Fregadolli P, Falavigna DL, Falavigna-Guilherme AL. Investigation of Cryptosporidium spp. and Giardia spp. in a public water-treatment system. Zoonoses Public Health. Jun 2009;56(5):221-8. [Medline].
Hill DR. Giardia lamblia. Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 2. 6th ed. Philadelphia, Pennsylvania: Churchill Livingstone An Imprint of Elsevier Inc.; 2005:3198-3203 / 277. [Full Text].
Huston CD. Intestinal Protozoa. Feldman M, Friedman LS, Brandt LJ. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Volume 2. 8th ed. Philadelphia, PA: Saunders, An imprint of Elsevier Inc.; 2006:2420-2423 / 106. [Full Text].
Robertson LJ, Forberg T, Gjerde BK. Giardia cysts in sewage influent in Bergen, Norway 15-23 months after an extensive waterborne outbreak of giardiasis. J Appl Microbiol. Apr 2008;104(4):1147-52. [Medline].
Ryu H, Alum A, Mena KD, Abbaszadegan M. Assessment of the risk of infection by Cryptosporidium and Giardia in non-potable reclaimed water. Water Sci Technol. 2007;55(1-2):283-90. [Medline].
Farthing MJ. Giardiasis. Gastroenterol Clin North Am. Sep 1996;25(3):493-515. [Medline].
Sears CL. Giardiasis. Goldman L, Ausiello D. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders , An Imprint of Elsevier Inc; 2007:2402-2404 / 372. [Full Text].
Monis PT, Thompson RC. Cryptosporidium and Giardia-zoonoses: fact or fiction?. Infect Genet Evol. Nov 2003;3(4):233-44. [Medline].
Huang DB, White AC. An updated review on Cryptosporidium and Giardia. Gastroenterol Clin North Am. Jun 2006;35(2):291-314, viii. [Medline].
Thompson RC, Palmer CS, O'Handley R. The public health and clinical significance of Giardia and Cryptosporidium in domestic animals. Vet J. Jul 2008;177(1):18-25. [Medline].
Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. Apr 2010;26(4):180-9. [Medline].
John CC. Giardiasis and Balantidiasis. In: Kliegman RM, Behrman BE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders, An imprint of Elsevier Inc; 2007:1462-1464 / 279.
Buret AG. Mechanisms of epithelial dysfunction in giardiasis. Gut. Mar 2007;56(3):316-7. [Medline].
Hill DR. Giardiasis. Issues in diagnosis and management. Infect Dis Clin North Am. Sep 1993;7(3):503-25. [Medline].
Hanevik K, Hausken T, Morken MH, Strand EA, Morch K, Coll P, et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect. Dec 2007;55(6):524-30. [Medline].
Buret AG. Pathophysiology of enteric infections with Giardia duodenalius. Parasite. Sep 2008;15(3):261-5. [Medline].
Faubert G. Immune response to Giardia duodenalis. Clin Microbiol Rev. Jan 2000;13(1):35-54, table of contents. [Medline]. [Full Text].
Buret AG. Immunopathology of giardiasis: the role of lymphocytes in intestinal epithelial injury and malfunction. Mem Inst Oswaldo Cruz. Mar 2005;100 Suppl 1:185-90. [Medline].
Garcia LS. Intestinal Protozoa: Flagellates and Ciliates. In: Diagnostic Medical Parasitology. 5th ed. Washington, D.C: ASM Press; 2007:36-49/3.
Roxström-Lindquist K, Palm D, Reiner D, Ringqvist E, Svärd SG. Giardia immunity--an update. Trends Parasitol. Jan 2006;22(1):26-31. [Medline].
Panaro MA, Cianciulli A, Mitolo V, Mitolo CI, Acquafredda A, Brandonisio O, et al. Caspase-dependent apoptosis of the HCT-8 epithelial cell line induced by the parasite Giardia intestinalis. FEMS Immunol Med Microbiol. Nov 2007;51(2):302-9. [Medline].
Liu C, Crawford JM. The Gastrointestinal Tract. In: Kumar V, Abbas AK, Fausto N. Robbins and Cotran: Pathologic Basis of Disease. 7th ed. Philadelphia: Saunders, An Imprint of Elsevier; 2005:840 / 17. [Full Text].
Cacciò SM, Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol. Aug 2008;160(2):75-80. [Medline].
Minvielle MC, Molina NB, Polverino D, Basualdo JA. First genotyping of Giardia lamblia from human and animal feces in Argentina, South America. Mem Inst Oswaldo Cruz. Feb 2008;103(1):98-103. [Medline].
Robertson LJ, Forberg T, Hermansen L, Gjerde BK, Langeland N. Molecular characterisation of Giardia isolates from clinical infections following a waterborne outbreak. J Infect. Jul 2007;55(1):79-88. [Medline].
Abdul-Wahid A, Faubert G. Characterization of the local immune response to cyst antigens during the acute and elimination phases of primary murine giardiasis. Int J Parasitol. May 2008;38(6):691-703. [Medline].
Dawson D. Foodborne protozoan parasites. Int J Food Microbiol. Aug 25 2005;103(2):207-27. [Medline].
Fort GG, Mikolich DJ, Policar M. Giardiasis. In: Ferri FF. Clinical Advisor 2009. Philadelphia, PA: Mosby, An Imprint of Elsevier; 2009:358.
Yoder JS, Beach MJ. Giardiasis surveillance--United States, 2003-2005. MMWR Surveill Summ. Sep 7 2007;56(7):11-8. [Medline].
Pickering LK. Giardia lamblia (Giardiasis). In: Long SS. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia, PA: Churchill Livingstone An imprint of Elsevier Inc; 2008:1241-1245/ 265. [Full Text].
Cacciò SM, Thompson RC, McLauchlin J, Smith HV. Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol. Sep 2005;21(9):430-7. [Medline].
Giangaspero A, Berrilli F, Brandonisio O. Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective. Parasitol Res. Oct 2007;101(5):1169-82. [Medline].
Laupland KB, Church DL. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect Dis. Sep 16 2005;5:72. [Medline]. [Full Text].
Hoque ME. Conn's Current Therapy 2008. In: Rakel RE, Bope ET. Giardiasis. 60th ed. Saunders, An imprint of Elsevier, Inc: Philadelphia, PA; 2008:64-67 / 15.
Dib HH, Lu SQ, Wen SF. Prevalence of Giardia lamblia with or without diarrhea in South East, South East Asia and the Far East. Parasitol Res. Jul 2008;103(2):239-51. [Medline].
Gelanew T, Lalle M, Hailu A, Pozio E, Cacciò SM. Molecular characterization of human isolates of Giardia duodenalis from Ethiopia. Acta Trop. May 2007;102(2):92-9. [Medline].
Quihui L, Morales GG, Méndez RO, Leyva JG, Esparza J, Valencia ME. Could giardiasis be a risk factor for low zinc status in schoolchildren from northwestern Mexico? A cross-sectional study with longitudinal follow-up. BMC Public Health. Feb 20 2010;10(1):85. [Medline]. [Full Text].
Thompson SC. Giardia lamblia in children and the child care setting: a review of the literature. J Paediatr Child Health. Jun 1994;30(3):202-9. [Medline].
Escobedo AA, Almirall P, Alfonso M, Cimerman S, Rey S, Terry SL. Treatment of intestinal protozoan infections in children. Arch Dis Child. Jun 2009;94(6):478-82. [Medline].
Jiménez JC, Pinon A, Dive D, Capron M, Dei-Cas E, Convit J. Antibody response in children infected with Giardia intestinalis before and after treatment with Secnidazole. Am J Trop Med Hyg. Jan 2009;80(1):11-5. [Medline].
Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol. Apr 21 2009;9:27. [Medline]. [Full Text].
Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. Dec 2007;19(12):977-82. [Medline].
Penrose AS, Wells EV, Aiello AE. Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome. World J Gastroenterol. Sep 14 2007;13(34):4574-8. [Medline].
Quihui L, Morales GG, Méndez RO, Leyva JG, Esparza J, Valencia ME. Could giardiasis be a risk factor for low zinc status in schoolchildren from northwestern Mexico? A cross-sectional study with longitudinal follow-up. BMC Public Health. Feb 20 2010;10(1):85. [Medline]. [Full Text].
Ouattara M, N'guéssan NA, Yapi A, N'goran EK. Prevalence and spatial distribution of Entamoeba histolytica/dispar and Giardia lamblia among schoolchildren in Agboville area (Côte d'Ivoire). PLoS Negl Trop Dis. Jan 19 2010;4(1):e574. [Medline]. [Full Text].
Nagaty IM, Hegazi MM. Dot-ELISA copro-antigen and direct stool examination in diagnosis of giardiasis patients. J Egypt Soc Parasitol. Aug 2007;37(2):641-8. [Medline].
Strand EA, Robertson LJ, Hanevik K, Alvsvåg JO, Mørch K, Langeland N. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clin Microbiol Infect. Nov 2008;14(11):1069-71. [Medline].
Youn S, Kabir M, Haque R, Petri WA Jr. Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol. Feb 2009;47(2):451-2. [Medline]. [Full Text].
Morken MH, Nysaeter G, Strand EA, Hausken T, Berstad A. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scand J Gastroenterol. 2008;43(2):141-5. [Medline].
Busatti HG, Vieira AE, Viana JC, Silva HE, Souza-Fagundes EM, Martins-Filho OA, et al. Effect of metronidazole analogues on Giardia lamblia cultures. Parasitol Res. Dec 2007;102(1):145-9. [Medline].
Monajemzadeh SM, Monajemzadeh M. Comparison of iron and hematological indices in Giardia lamblia infection before and after treatment in 102 children in Ahwaz, Iran. Med Sci Monit. Jan 2008;14(1):CR19-23. [Medline].
Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother. Aug 2007;8(12):1885-902. [Medline].
Kiser JD, Paulson CP, Brown C. Clinical inquiries. What's the most effective treatment for giardiasis?. J Fam Pract. Apr 2008;57(4):270-2. [Medline].
Gardner TB, Hill DR. Treatment of giardiasis. Clin Microbiol Rev. Jan 2001;14(1):114-28. [Medline]. [Full Text].
Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf. Nov 2003;2(6):529-41. [Medline].
Busatti HG, Santos JF, Gomes MA. The old and new therapeutic approaches to the treatment of giardiasis: Where are we?. Biologics. 2009;3:273-87. [Medline]. [Full Text].
Bailey JM, Erramouspe J. Nitazoxanide treatment for giardiasis and cryptosporidiosis in children. Ann Pharmacother. Apr 2004;38(4):634-40. [Medline].

